European Medicines Agency Begins Review of First Human Lyme Disease Vaccine

A significant step has been taken in the fight against Lyme disease as the European Medicines Agency (EMA) begins evaluating the application for a vaccine candidate developed by Pfizer and Valneva, which could become the first human vaccine against the disease in Europe if approved.

Post Share

Sources

Showing 0 of 1 sources

No articles available in your preferred languages.

1 article available in other languages below.

delfi-ltLithuanian2d ago

Istorinis žingsnis kovoje su Laimo liga: Europoje pradės vertinti vakciną

Kovojant su Laimo liga žengtas svarbus žingsnis – Europos vaistų agentūra (EMA) pradės vertinti „Pfizer“ ir „Valneva“ sukurtos vakcinos kandidatės paraišką. Jei vakcina būtų patvirtina, ji galėtų tapti pirmąja žmonėms skirta vakcina nuo Laimo ligos Europoje.

Read full article →

PERSPECTA

PERSPECTA

European Medicines Agency Begins Review of First Human Lyme Disease Vaccine

Sources

Istorinis žingsnis kovoje su Laimo liga: Europoje pradės vertinti vakciną

Related Stories

Hayden Panettiere's Health Struggles Before Her Death Revealed

Airline Pilots Face Highest Cancer Risk from Radiation Exposure

Study Reveals Elderly More Vulnerable to Extreme Heat Than Previously Thought

Nollywood Actor Ogogo Hassan's Daughters Seek Help for Father's Stage 4 Cancer

PERSPECTA